Clinical trial
Bevacizumab+folfiri in untreated patients with advanced colorectal cancer. A phase II multicenter study of the Gruppo Oncologico dell'Italia Meridionale. (GOIM).
The main objectives are to determine the objectively confirmed response rate and time-to- progression.
| Category | Value |
|---|---|
| Study start date | 2007-06-26 |